BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 24618011)

  • 21. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
    Tian H; Chen S; Zhang C; Li M; Zheng H
    Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep integrative analysis of microRNA-mRNA regulatory networks for biomarker and target discovery in chondrosarcoma.
    Sui J; Liu Q; Zhang H; Kong Y
    J Cell Biochem; 2019 Jun; 120(6):9631-9638. PubMed ID: 30520120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
    Sun Y; Li SH; Cheng JW; Chen G; Huang ZG; Gu YY; Yan HB; He ML
    Biomed Res Int; 2020; 2020():6037434. PubMed ID: 33178832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.
    Afshar AS; Xu J; Goutsias J
    PLoS One; 2014; 9(6):e100806. PubMed ID: 24968068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study.
    Alshalalfa M; Bader GD; Goldenberg A; Morris Q; Alhajj R
    BMC Syst Biol; 2012 Aug; 6():112. PubMed ID: 22929553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
    Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
    Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.
    Fu J; Tang W; Du P; Wang G; Chen W; Li J; Zhu Y; Gao J; Cui L
    BMC Syst Biol; 2012 Jun; 6():68. PubMed ID: 22703586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
    Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
    Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of aberrant miRNA-mRNA interaction networks in prostate cancer to conjecture its molecular mechanisms.
    Peng S; Liu C; Fan X; Zhu J; Zhang S; Zhou X; Wang T; Gao F; Zhu W
    Cancer Biomark; 2022; 35(4):395-407. PubMed ID: 36373308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.
    Erdmann K; Kaulke K; Thomae C; Huebner D; Sergon M; Froehner M; Wirth MP; Fuessel S
    BMC Cancer; 2014 Feb; 14():82. PubMed ID: 24517338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.